Payam Pet Scan

Description

In the Name of empathy, patient satisfaction, and employee engagement, “PAYAM PET SCAN” was introduced in 2016 to continue building a strong base of engaged and committed caregivers who are dedicated to fulfilling PAYAM’s mission of putting patients first. PAYAM PET SCAN is the First private PET scan center equipped with PET-CT, PET-MAMMO, Cyclotron, and Conventional Nuclear Medicine, and the first phase of a CANCER CENTER OF EXCELLENCE.

Payam Pet Scan Services

PET-CT Scan

PET/CT represents a major paradigm shift in diagnosis: it takes us from conventional technologies that evaluate structural anatomy to a molecular modality that images the metabolic activity of the tissue.

PET-Mammography

Several imaging modalities have been introduced over recent years to better screen for and stage breast cancer. Positron emission mammography (PEM) has been approved by the US FDA and introduced into clinical use as a diagnostic adjunct to mammography and breast ultrasonography.

Conventional Nuclear Medicine

Conventional nuclear medicine imaging can be performed using various radiopharmaceuticals, mainly labeled with technetium-99m, and also uses gallium, thallium, and 131-I.

Overview of Payam Pet Scan Services

PET-CT

The various utilities of PET/CT in oncology can be categorized as follows:

• Diagnosis
• To characterize a lesion to suggest whether it is benign or malignant
• For the detection of a possible primary when the patient presents with metastases
• To identify an appropriate site from which a biopsy would yield adequate representative tissue for diagnosis
• Detection of malignancy when tumor markers are abnormal
• Staging 

After the histological diagnosis, to assess the extent of the disease before the start of treatment

• Response Evaluation: Assessment of response to treatment during or after therapy.
• Restaging: Assessment of the extent of the disease after treatment or after confirmed recurrence.
• Suspected Recurrence: Assessment of disease following clinical or biochemical suspicion of recurrence.
• Follow-up or Surveillance: Assessment of disease in the absence of critical evidence of recurrence.
• Radiotherapy Planning (RT): When the study is used for contouring and planning the radiation fields.

PET-MAMMO

• Screening in dense breasts, hindering mammography/ultrasound
• Screening in (very) high-risk patients
• Occult lesion on conventional imaging
• Inconclusive lesion on mammography/ultrasound
• Accurate FDG uptake determination in heterogeneous lesions
• Primary tumor response monitoring (in node-negative patients)
• FDG-guided biopsies

Advantage of Payam Pet Scan

Positron Emission tomography/ computerized tomography (PET/CT) is a technological advancement having a significant impact on oncology. 18Fluorine-2-fluoro-2-deoxy-D-glucose (18F-FDG) is an expensive, short-lived radiopharmaceutical used for PET/CT scanning and is synthesized in a cyclotron by a complex process. The net result is an expensive modality.

PAYAM PET SCAN CENTER has an advantage in that uses a dose of on-demand cyclotron which means we could do PET-CT 24 hours a day and 7 days of a week.